Skip to main content
. 2020 Jan 21;26(3):353–365. doi: 10.3748/wjg.v26.i3.353

Figure 1.

Figure 1

PRISMA 2009 Flow diagram describing the selection of the studies reporting programmed cell death-1 inhibitor-related cholangitis for our review.